×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

PAREXEL's Chuck Stevens, VP to Speak at DIA 2014

May 14, 2014
I'm Chuck Stevens, Vice President and General Manager of Commercialization Strategy here at PAREXEL. Please make plans to attend a very important session that I am chairing at the Drug Information Association annual meeting in San Diego on Tuesday, June 17 at 10:30 in the morning. The session is in Track 13 and entitled, "Drug Development with Reimbursement in Mind: Obtaining the Input of Payers to Inform Clinical Trial Design." In many major markets today, newly approved drugs are facing an increased challenge in obtaining commercial success due to public and private payer bodies not affording patients access to therapy. This session focuses on how bio-pharmaceutical companies can align and work with payers to help shape development strategies that give the post approval market the data necessary to support patient access and commercial success. I will be joined by two panelists, one from Pfizer and one from Humana, who will present data from a recent collaboration that helps to showcase the concept of sponsors and payers working together. I look forward to seeing you at my session, "Drug Development with Reimbursement in Mind: Obtaining the Input of Payers to Inform Clinical Trial Design" on Tuesday, June 17 at 10:30 in sunny San Diego.
Previous Video
PAREXEL's Jeffery Fairbairn, Senior Director to Speak at DIA 2014
PAREXEL's Jeffery Fairbairn, Senior Director to Speak at DIA 2014

Hi, my name is Jeff Fairbairn. I am a Senior Director at PAREXEL, and the head of Study Optimization Servi...

Next Video
PAREXEL MARCH 11 2014h264
PAREXEL MARCH 11 2014h264